Kilitch Drugs (India) Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting

Kilitch Drugs' board approved the financial results for the quarter and half-year. Consolidated H1 net sales grew to ₹92.06 Cr from ₹80.92 Cr, with profit after tax for owners at ₹11.21 Cr. Company also completed a ₹49.92 Cr rights issue for its Greenfield Project.